IOMED is a Data Space Platform that transforms and standardizes clinical data (including unstructured text) into OMOP CDM, mediates governed access through a federated processing model within hospital environments, and supports secondary-use workflows for research and real-world evidence generation.
Published Oct 9, 2026
| Starting Price | Not public (demo / custom) | Not public (enterprise) | Not public (sales-led) |
| Primary use case | EU/EHDS-oriented federated secondary-use workflows; hospitals aiming for OMOP enablement and mediated data access | Large federated RWD network with feasibility and analytics capabilities | Oncology-focused regulatory-grade datasets and evidence generation |
| Key Strength | Emphasis on OMOP standardization and a federated mediation model | Broad federated network and self-service querying for feasibility | Deep oncology clinical data models and extensive publication adoption |
| Key Weakness | Limited public third-party reviews; pricing opacity; limited public detail on enterprise security features beyond ISO claims | Pricing not transparent; data harmonization may vary by site; may not be OMOP-centric in all deployments | Narrower disease focus (oncology); sales-led access model; not primarily an OMOP enablement tool |
—
IOMED versus TriNetX: Both vendors support federated network approaches and privacy-oriented access. TriNetX emphasizes a large federated network and self-service querying; IOMED emphasizes EHDS alignment and OMOP-centric enablement and mediation. Organizations that prioritize EU regulatory alignment and OMOP standardization may find IOMED’s framing relevant; organizations that prioritize broad global network scale and an established global brand may consider TriNetX.
IOMED versus Flatiron: Flatiron is specialized in oncology and has an extensive publication record. IOMED is oriented toward multi-disease enablement and hospital-side mediation into OMOP. Organizations with primary oncology evidence-generation needs may find Flatiron more immediately relevant; organizations seeking multi-hospital OMOP enablement and federated mediation in the EU may find IOMED’s approach more aligned.
IOMED versus IQVIA and large data aggregators: IQVIA provides multiple RWD assets and services across a large data ecosystem; IOMED’s public positioning is closer to infrastructure and mediation with federated processing and OMOP enablement.